Product Information
TOBRAMYCIN 0.3% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.1081 per ML under NDC 62332051805. Its NADAC has been published 372 times since Aug 21, 2019.
FDA first approved this application on Apr 19, 2019. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332051805
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TOBRAMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA211847FDA Approved
4/19/2019
TE Code
AT
On Market Since
4/19/2019
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 0.3% EYE DROP has been published 372 times since Aug 21, 2019, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1081 per ML |
|---|---|
| All-time high | $1.8050 (Sep 14, 2022) |
| All-time low | $0.7286 (Jul 17, 2024) |
| 52-week high | $1.1579 |
| 52-week low | $1.0024 |
| Median price | $1.3180 |
| Average price | $1.2940 |
| Largest weekly change | +63.0% (Jun 19, 2024) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tobramycin Ophthalmic Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tobramycin Ophthalmic Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 0.3% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $1.1081 per ML (NDC 62332051805), effective Sep 30, 2026.
How has the price of TOBRAMYCIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 0.3% EYE DROP has declined 12.2%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 0.3% EYE DROP?
Since Aug 21, 2019, the NADAC for TOBRAMYCIN 0.3% EYE DROP has ranged from a low of $0.7286 (Jul 17, 2024) to a high of $1.8050 (Sep 14, 2022), with a median of $1.3180 per ML.
Are there cheaper alternatives to TOBRAMYCIN 0.3% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 0.3% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOBRAMYCIN 0.3% EYE DROP?
TOBRAMYCIN 0.3% EYE DROP (NDC 62332051805) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.